Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Mimosa bark from species like Mimosa tenuiflora contains bioactive compounds including betulinic acid, DMT, and terpenoid saponins that demonstrate antimicrobial and anti-inflammatory properties. The bark exhibits antioxidant activity with DPPH scavenging IC50 values of 17.21 μg/mL and shows cytotoxic effects against tumor cell lines with approximately 86% growth inhibition.
Reported Benefits (Provisional)
Origin & History
Mimosa Bark (Albizia julibrissin), also known as the "Persian Silk Tree," is native to tropical and subtropical regions of Asia, including China and Iran, and parts of South America. This delicate yet potent bark is revered for its profound calming and mood-enhancing properties.
Research Narrative (Provisional)
Scientific studies on Mimosa Bark explore its mood-enhancing, neuroprotective, and adaptogenic effects, particularly its influence on neurotransmitter balance and stress resilience. Research supports its traditional use for alleviating anxiety, promoting restful sleep, and enhancing cognitive function.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Minerals: Zinc, Iron, Magnesium, Calcium. - Other: Essential amino acids, Dietary fiber. - Phytochemicals & Bioactives: Saponins, Flavonoids (Quercetin, Kaempferol), Alkaloids, Lignans, Polyphenols, Tannins, Triterpenoids.
Reported Mechanism (Provisional)
Betulinic acid induces cytotoxicity through growth inhibition in tumor cell lines, while terpenoid saponins (mimonoside A, B, C) provide antimicrobial and anti-inflammatory actions. DMT and serotonin act on serotonergic pathways with potential mood-modulating effects. Flavonoids and polyphenols neutralize free radicals through DPPH and ABTS scavenging mechanisms.
Clinical Narrative (Provisional)
Clinical evidence remains limited, with one patent documenting standardized M. tenuiflora bark extracts (≥12% w/w tannins) showing confirmed antimicrobial and wound healing effects in patients with treatment-resistant skin ulcers. In vitro studies demonstrate antimicrobial activity against S. aureus and M. luteus (MIC 10.0 μg/mL) and E. coli (MIC 20.0 μg/mL). No large-scale randomized controlled trials with quantified clinical endpoints have been published. Current evidence relies primarily on traditional use documentation and laboratory studies.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.